Developing the Next Big Vaccine Technologies
Summary: We are in a new era of possibilities with vaccines. The rapid development of safe and efficacious mRNA vaccines was a triumph for biopharma that has propelled the entire vaccine field — once relegated to the backwaters of biotech R&D — straight into a first-class concern for investors and dealmakers. So, what’s next? In this panel discussion, Endpoints News publisher, Arsalan Arif convenes some of the field’s top experts to discuss the techniques and technologies they are working on including self-amplifying RNA, virus-like particles, “pan-viral vaccines”, and scaling up mRNA.